SIRPB1 and central nervous system cancer: Elevated SIRPB1 levels correlated with worse OS and PFI in these specific patient categories, as shown in Fig. 8H and Additional file 1: Figure S2C, emphasizing the SIRPB1’s role in affecting the prognosis of glioma patients with varied pathological features.